Biotechnological Approaches to Develop Personalized Medicines for Rare Genetic Disorders

Abstract

Less than 5 out of 10,000 people have a rare condition. However, many find them harmful; the World Health Organisation (WHO) estimates that 7,000 uncommon diseases impact 7% of the world's population. This viewpoint discusses advancements in diagnosis, treatment, and prevention with an emphasis on hereditary metabolic disorders. There is a discussion of the obstacles to the discovery, creation, and application of treatments unique to uncommon diseases. Utilising innovative strategies, care networks, and collaborative frameworks is advised in order to fully realise the potential of personalised genomic medicine in order to lower morbidity and improve the standard of living for these vulnerable patients. Through the use of techniques like gene expression, CRISPR-Cas technologies, and genetic engineering of cell models and model organisms, it is possible to identify biomarkers for disease activity and diagnosis, develop therapeutic strategies, and uncover disease mechanisms through a process known as "translational medicine."